desvenlafaxine succinate
desvenlafaxine succinate is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including Pristiq Extended-Release, desvenlafaxine. Available dosage forms: tablet, extended release, powder.
Drug Details
- Generic Name
- desvenlafaxine succinate
- Brand Names
- Pristiq Extended-Release, desvenlafaxine
- Application Number
- NDA021992
- Sponsor
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- NDC Codes
- 8
- Dosage Forms
- TABLET, EXTENDED RELEASE, POWDER
- Routes
- ORAL
- Active Ingredients
- DESVENLAFAXINE SUCCINATE
Indications and Usage
1 INDICATIONS AND USAGE Desvenlafaxine extended-release tablet is indicated for the treatment of adults with major depressive disorder (MDD) [see CLINICAL STUDIES ( 14 )]. Desvenlafaxine extended-release tablet, is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).